Clinical Trial Update: Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer Patients [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating the combination of chidamide and zimberelimab for metastatic triple-negative breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Chidamide (chidamide)
• Zimberelimab (zimberelimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: COMPLETED